EP-1812: Adaptive VMAT for cT1-2aN0M0 laryngeal cancer: potential risk of target volume over dosage. (April 2016) - Bijl, H.P.; Korevaar, E.W.; Gelderman, M.; Langendijk, J.A.; Kierkels, R.G.J.